Cellectis S.A.
ALCLS.PA · PAR
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | €35,172 | €16,725 | €10,655 | €12,717 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Cost of Goods Sold | €2,357 | €2,425 | €2,015 | €0 |
| Gross Profit | €32,815 | €14,300 | €8,640 | €12,717 |
| % Margin | 93.3% | 85.5% | 81.1% | 100% |
| R&D Expenses | €24,069 | €23,080 | €21,932 | €20,866 |
| G&A Expenses | €2,479 | €2,289 | €2,333 | €3,449 |
| SG&A Expenses | €2,479 | €2,289 | €2,333 | €3,449 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€1,774 | -€1,482 | -€1,446 | -€918 |
| Operating Expenses | €24,774 | €23,887 | €22,819 | €23,397 |
| Operating Income | €8,041 | -€9,587 | -€14,179 | -€10,680 |
| % Margin | 22.9% | -57.3% | -133.1% | -84% |
| Other Income/Exp. Net | -€7,452 | -€14,149 | -€3,948 | €17,117 |
| Pre-Tax Income | €589 | -€23,736 | -€18,127 | €6,437 |
| Tax Expense | €0 | -€1 | €1 | €514 |
| Net Income | €589 | -€23,735 | -€18,128 | €5,922 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS | 0.006 | -0.24 | -0.18 | 0.066 |
| % Growth | 102.5% | -33.3% | -373.1% | – |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.066 |
| Weighted Avg Shares Out | 100,325 | 100,157 | 100,157 | 89,852 |
| Weighted Avg Shares Out Dil | 100,325 | 100,157 | 100,157 | 89,852 |
| Supplemental Information | – | – | – | – |
| Interest Income | €2,313 | €2,195 | €2,912 | €3,570 |
| Interest Expense | €2,107 | €2,055 | €1,911 | €1,908 |
| Depreciation & Amortization | €5,011 | €5,017 | €4,931 | €5,829 |
| EBITDA | €7,707 | -€16,664 | -€11,285 | €14,174 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |